Jennifer B. Green, MD
Professor of Medicine
Division of Endocrinology
Department of Medicine
Duke University Medical Center
Duke Clinical Research Institute
Durham, North Carolina
Mikhail Kosiborod, MD
Professor of Medicine
Kansas City School of Medicine
University of Missouri
Consulting Cardiologist Division of Cardiovascular Research
Department of Cardiology
Saint Luke's Mid America Heart Institute
Kansas City, Missouri
STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.
DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.
The following faculty reported relevant financial relationships:
- Jennifer B. Green, MD: Consultant, AstraZeneca, Boehringer Ingelheim/Lilly, Hawthorne Effect/Omada, Novo Nordisk, Pfizer, Sanofi/Lexicon; Research Support, AstraZeneca, Boehinger Ingelheim/Lilly, Roche, Sanofi/Lexicon
- Mikhail N. Kosiborod, MD: Consultant, Amgen, Applied Therapeutics, AstraZeneca, Bayer, Boehringer Ingelheim, Janssen, Lilly, Merck; Research Support, AstraZeneca, Bayer, Boehringer Ingelheim
The following SPC member who planned and reviewed content for this activity reported relevant financial relationships:
- Andjela T. Drincic, MD: Advisory Board Member: Corcept Therapeutics
The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.
Disclosure information for presenters is included in their individual recorded presentations.
The following SPC members reported no relevant financial relationships:
- Howard S. Blank, MD; Beret Ann Casey, MD; Lediya Cheru, MD; Marcelo Correia, MD, PhD; Angela M. Leung, MD; Kelly Lauter Roszko, MD, PhD; Virginia D. Sarapura, MD; Soleymani Taraneh, MD; Savitha Subramanian, MD
The ES and CCO staff involved in the development of this CME activity reported no relevant financial relationships.
ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company. Provided by the Endocrine Society in collaboration with Clinical Care Options
The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable